Author
Sebastian J. Reinstadler
Also Known As
Aram Chilingaryan, Hamlet G Hayrapetyan, J. Reinstadler Sebastian, Marber, M, RS Toole, Reinstadler, Sebastian Johannes, S J Reinstadler, S Reinstadler, S. Reinstadler, S.J Reinstadler
228
Publications
6.8K
Citations
35
H-Index
56
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 17 | 22 | 768 |
2 | Public Health | 9 | 9 | 308 |
3 | Engineering | 2 | 2 | 72 |
4 | Health Sciences | 1 | 1 | 55 |
5 | Biomedical Engineering | 1 | 1 | 44 |
Sebastian J. Reinstadler
×
72
Publications
3K
Citations
32
H-Index
| Year | Citations | |
|---|---|---|
2020 | 634 | |
2018 | 110 | |
2019 | 105 | |
Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial Axel Bauer, Michael Schreinlechner, Nikolay Sappler, The Lancet Respiratory Medicine Open-label TrialHypertensionCardiovascular DiseaseAntihypertensive TherapyClinical Trials | 2021 | 101 |
2017 | 93 | |
2016 | 85 | |
2013 | 68 | |
2018 | 66 | |
2015 | 58 | |
2017 | 58 |
Page 1
Page 1